$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?
10:20am, Tuesday, 13'th Sep 2022 Zacks Investment Research
Style Box ETF report for FDL
3 Unstoppable Dividend Stocks to Buy in September
09:25am, Tuesday, 13'th Sep 2022 The Motley Fool
These stocks offer more than just dividends.
3 Unstoppable Dividend Stocks to Buy in September
05:25am, Tuesday, 13'th Sep 2022
These stocks offer more than just dividends.
AbbVie (ABBV) Gains But Lags Market: What You Should Know
09:45pm, Monday, 12'th Sep 2022 Zacks Investment Research
AbbVie (ABBV) closed the most recent trading day at $142.24, moving +0.58% from the previous trading session.
Wells Fargo's Mohit Bansal: Abbvie has better long-term opportunity than Bristol-Myers
04:38pm, Monday, 12'th Sep 2022
Mohit Bansal, Wells Fargo, joins 'Closing Bell' to discuss Bristol-Myers shares rising on the FDA approval of its latest drug.
2 Dividend Aristocrats to Buy for Passive Income That Could Outperform the Market
10:27am, Monday, 12'th Sep 2022 The Motley Fool
This pair of Midwestern companies have outperformed in recent years, and their futures look brighter than ever.
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF (PJP)?
10:20am, Monday, 12'th Sep 2022 Zacks Investment Research
Sector ETF report for PJP
2 Dividend Aristocrats to Buy for Passive Income That Could Outperform the Market
06:27am, Monday, 12'th Sep 2022
This pair of Midwestern companies have outperformed in recent years, and their futures look brighter than ever.
4 S&P 500 Dividend Aristocrat Dogs To Buy, 1 To Watch
03:18pm, Sunday, 11'th Sep 2022
"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com/Investing. 65 Aristocrats screened as of September 8, 2022 re
Best Stocks To Buy Now? 4 Biotech Stocks In Focus
12:10pm, Sunday, 11'th Sep 2022
Is now a good time to add these biotech stocks to your watchlist?
Become Financially Independent, Stress-Free In 15 Years
01:00pm, Saturday, 10'th Sep 2022 Seeking Alpha
Being financially independent is a prerequisite for retirees but can be a great stress reducer for younger folks who are several years away from retirement. Read more here.
Bert's August Dividend Income Report | Dividend Investing 2022
08:27am, Saturday, 10'th Sep 2022 Seeking Alpha
Each month, we share our dividend income summaries to highlight our growth and progress. We received $842.78 in August dividend income! This was a 3.54% increase compared to August 2021.
Revance (RVNC) Gets FDA Nod for Anti-Wrinkle Product, Stock Up
06:39pm, Friday, 09'th Sep 2022 Zacks Investment Research
FDA approves Revance Therapeutics' (RVNC) Daxxify as a long-acting neuromodulator with a strong label that includes 36-week efficacy data from the SAKURA clinical program.
Is Most-Watched Stock AbbVie Inc. (ABBV) Worth Betting on Now?
01:00pm, Friday, 09'th Sep 2022 Zacks Investment Research
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Is Most-Watched Stock AbbVie Inc. (ABBV) Worth Betting on Now?
10:32am, Friday, 09'th Sep 2022
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Sign In
Buy ABBV